Manufacturer record
RPL (India) Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by RPL (India) Pharmaceuticals Pvt. Ltd (Delhi) were declared Not of Standard Quality between August 2020 and October 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: DBE14, Diclofenac Sodium Tablets IP 50 mg (exp Feb 2025). RDTL Chandigarh (CDSCO lab) found it not of standard quality: Description. Listed in the October 2023 alert.
Records by type
2 records linked to RPL (India) Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium Tablets IP 50 mg | Batch DBE14Mfg Mar 2023 · Exp Feb 2025 | DescriptionDescription | RDTL ChandigarhCDSCO lab | Oct 2023 |
| Ethyl Alcohol Solution 70% (Handzon Instant Hand Sanitizer) | Batch HDZC-016Mfg May 2020 · Exp Apr 2022 | Assay of EthanolAssay | RDTL ChandigarhState lab | Aug 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.